PLA1A and melanoma: As expected, melanoma patients with PLA1A1-high tumors had significantly shorter DFS compared to that in patients with PLA1A-low tumors (5-year DFS rate: 69.3% vs 75.4%, p = 0.026) (Fig. 5A).